236 related articles for article (PubMed ID: 30561117)
1. Value of radiotherapy in addition to esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma: Analysis of surveillance, epidemiology, and end results database.
Yu J; Ouyang W; Li Y; Hu J; Xu Y; Wei Y; Liao Z; Liu Y; Zhang J; Xie C
Cancer Med; 2019 Jan; 8(1):21-27. PubMed ID: 30561117
[TBL] [Abstract][Full Text] [Related]
2. A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy.
Yu S; Zhang W; Ni W; Xiao Z; Wang Q; Zhou Z; Feng Q; Zhang H; Chen D; Liang J; Lv J; Hui Z; He J; Gao S; Sun K; Fang D; Liu X; Li Y
Radiother Oncol; 2019 Nov; 140():159-166. PubMed ID: 31302346
[TBL] [Abstract][Full Text] [Related]
3. Does surgery improve outcomes for esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008.
Worni M; Martin J; Gloor B; Pietrobon R; D'Amico TA; Akushevich I; Berry MF
J Am Coll Surg; 2012 Nov; 215(5):643-51. PubMed ID: 23084493
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of surgery plus postoperative radiotherapy or definitive radiotherapy in older patients with thoracic esophageal squamous cell cancer.
Jiang W; Sun X; Zhou B; Han C; Liu F; Zheng J; Sun X
J Cancer Res Ther; 2019; 15(4):849-856. PubMed ID: 31436242
[TBL] [Abstract][Full Text] [Related]
5. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
[TBL] [Abstract][Full Text] [Related]
6. Postoperative radiotherapy for the young-old patients with thoracic esophageal squamous cell carcinoma: A 2-center experience.
Ding W; Yang M; Jiang W; Ge X; Sun X; Zhou B; Liu F; Jiang K; Shen F; Sun X
Medicine (Baltimore); 2020 Apr; 99(17):e19453. PubMed ID: 32332598
[TBL] [Abstract][Full Text] [Related]
7. Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?
Zou B; Tu Y; Liao D; Xu Y; Wang J; Huang M; Ren L; Zhu J; Gong Y; Liu Y; Zhou L; Zhou X; Peng F; Lu Y
Thorac Cancer; 2020 Mar; 11(3):631-639. PubMed ID: 31943824
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant radiotherapy for stage pN1M0 esophageal squamous cell carcinoma: Results from a Chinese two-center study.
Ni W; Chen J; Xiao Z; Yu S; Zhang W; Zhou Z; Chen D; Feng Q; Chen X; Lin Y; Zhu K; Gao S; Xue Q; Mao Y; Cheng G; Sun K; Liu X; Fang D
Thorac Cancer; 2019 Jun; 10(6):1431-1440. PubMed ID: 31102336
[TBL] [Abstract][Full Text] [Related]
9. Nomogram to Predict Overall Survival for Thoracic Esophageal Squamous Cell Carcinoma Patients After Radical Esophagectomy.
Deng W; Zhang W; Yang J; Ni W; Yu S; Li C; Chang X; Zhou Z; Chen D; Feng Q; Chen X; Lin Y; Zhu K; Zheng X; He J; Gao S; Xue Q; Mao Y; Cheng G; Sun K; Liu X; Fang D; Chen J; Xiao Z
Ann Surg Oncol; 2019 Sep; 26(9):2890-2898. PubMed ID: 31183641
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant radiotherapy for patients with pathologic node-negative esophageal carcinoma: A population based propensity matching analysis.
Gao HJ; Shang XB; Gong L; Zhang HD; Ren P; Shi GD; Wei YC; Yu ZT
Thorac Cancer; 2020 Feb; 11(2):243-252. PubMed ID: 31828980
[TBL] [Abstract][Full Text] [Related]
11. [Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma].
Pan W; Xiang Y; Gu Z; Ji C; Mao T; Fang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1045-1049. PubMed ID: 28900998
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the causes of failure after radical surgery in patients with
Shen WB; Gao HM; Zhu SC; Li YM; Li SG; Xu JR
World J Surg Oncol; 2017 Oct; 15(1):192. PubMed ID: 29070049
[TBL] [Abstract][Full Text] [Related]
13. The impact of geriatric nutritional risk index on surgical outcomes after esophagectomy in patients with esophageal cancer.
Kubo N; Sakurai K; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Yashiro M; Ohira M
Esophagus; 2019 Apr; 16(2):147-154. PubMed ID: 30311102
[TBL] [Abstract][Full Text] [Related]
14. [Factors affecting on long-time survival in patients with stage Ⅲ thoracic esophageal carcinoma after esophagectomy].
Yang Q; Wang YX; He M; Li J; Qi Z; Zhu SC; Qiao XY
Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):530-7. PubMed ID: 27531268
[TBL] [Abstract][Full Text] [Related]
15. Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma.
Ni W; Yang J; Deng W; Xiao Z; Zhou Z; Zhang H; Chen D; Feng Q; Liang J; Lv J; Wang X; Wang X; Zhang T; Bi N; Deng L; Wang W
BMC Cancer; 2020 Feb; 20(1):144. PubMed ID: 32087687
[TBL] [Abstract][Full Text] [Related]
16. Prognostic evaluation of esophageal cancer patients with stages I-III.
Qiu MJ; Yang SL; Wang MM; Li YN; Jiang X; Huang ZZ; Xiong ZF
Aging (Albany NY); 2020 Jul; 12(14):14736-14753. PubMed ID: 32701062
[TBL] [Abstract][Full Text] [Related]
17. Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study.
Schwer AL; Ballonoff A; McCammon R; Rusthoven K; D'Agostino RB; Schefter TE
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):449-55. PubMed ID: 18538500
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy improves the survival of patients with metastatic esophageal squamous cell carcinoma: a propensity score matched analysis of Surveillance, Epidemiology, and End Results database.
Zhang R; Jia M; Li P; Han J; Huang K; Li Q; Qiao Y; Xu T; Ruan P; Hu Q; Fan G; Song Q; Fu Z
Dis Esophagus; 2019 Jan; 32(1):. PubMed ID: 30277502
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.
Yen YC; Chang JH; Lin WC; Chiou JF; Chang YC; Chang CL; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
Cancer; 2017 Jun; 123(11):2043-2053. PubMed ID: 28152166
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic influence of preoperative Nutritional Risk Screening -2002 (NRS-2002) score for patients with thoracic esophageal squamous cell carcinoma receiving surgery].
Sun HJ; Guo XW; Ji SJ; Zhou SB; Gu L
Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):917-921. PubMed ID: 30605983
[No Abstract] [Full Text] [Related]
[Next] [New Search]